| Results summary | View all lists in GO:BiolProc | View all genes in C02A.profile.d50 |
anatomical structure development The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome. enrichment: 1.72-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 1598_G_AT | GAS6 | G | S | growth arrest-specific 6 | |||||||||
| 206267_S_AT | MATK | G | D | P | S | megakaryocyte-associated tyrosine kinase | |||||||
| 215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 210771_AT | PPARA | T | D | E | R | peroxisome proliferator-activated receptor alpha | |||||||
| 212249_AT | PIK3R1 | G | D | X | E | P | S | phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha) | |||||
| 221675_S_AT | CHPT1 | E | choline phosphotransferase 1 | ||||||||||
| 203942_S_AT | MARK2 | D | P | S | MAP/microtubule affinity-regulating kinase 2 | ||||||||
| 205231_S_AT | EPM2A | D | E | P | epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) | ||||||||
| 204101_AT | MTM1 | D | E | P | myotubularin 1 | ||||||||
| 206409_AT | TIAM1 | D | S | T-cell lymphoma invasion and metastasis 1 | |||||||||
| 208127_S_AT | SOCS5 | D | X | S | suppressor of cytokine signaling 5 | ||||||||
| 205327_S_AT | ACVR2A | G | D | P | S | activin A receptor, type IIA | |||||||